Quick Summary:
In the fast-paced world of healthcare, effective and efficient response to life-threatening situations has become a priority. The global defibrillators market offers vital tools for dealing with serious cardiac health issues, such as ventricular fibrillation, cardiac arrhythmia and pulseless ventricular tachycardia. Affected by multiple conditions, like hypertension, diabetes, atherosclerosis, and stroke, an increasing number of individuals globally are facing the risk of cardiovascular diseases (CVDs) and sudden cardiac arrest (SCA). This has resulted in the expanding need for defibrillators, an important tool for healthcare professionals to restore normal heart functioning.
Technological advancements in the field of defibrillators are proving essential for improved patient care. The development of wearable cardioverter defibrillators (WCDs) is opening new avenues for predicting SCA risks, providing healthcare professionals with knowledge to intervene at the right time. The adoption of these innovations across healthcare centers globally is expected to fuel the growth of the defibrillators market. Additionally, various favorable policies promoting awareness and training, along with increased R&D activities and considerable investments in the healthcare sector by governments, are anticipated to further propel market growth. This market research report offers an in-depth analysis of the key market trends, highly valuable for strategic investment and planning.
A defibrillator refers to a medical device that delivers a therapeutic shock to the patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia and pulseless ventricular tachycardia. It aids in restoring a normal heartbeat by sending electric pulses or shockwaves to the heart. Some of the common types of defibrillators include automated external defibrillators (AED), manual/wearable external defibrillators, implantable cardioverter defibrillators (ICDs) and transvenous or subcutaneous implantable cardioverter defibrillators. These devices are primarily used in hospitals, clinics, cardiac centers, home care settings and prehospital care settings.
The increasing prevalence of cardiovascular diseases (CVDs) and sudden cardiac arrest (SCA) across the globe is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other related ailments, such as diabetes, atherosclerosis, hypertension and stroke, which is facilitating the product adoption across both the developed and emerging nations. Furthermore, widespread adoption of ICDs across healthcare centers is also providing a boost to the market growth. Modern ICDs are integrated with innovative subcutaneous and transvenous patches that aid in improving the overall efficiency and level of comfort for the patient. Additionally, various technological advancements and the development of wearable cardioverter defibrillators (WCDs) that can aid in predicting the risks of SCAs, are also creating a positive impact on the market growth. Other factors, including the implementation of favorable policies to promote training and awareness regarding defibrillators, along with extensive research and development (R&D) activities and increasing government investments in the healthcare sector, are projected to drive the market further.
Key Market Segmentation
The report provides an analysis of the key trends in each sub-segment of the global defibrillators market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type and end-user.Breakup by Product Type:
- Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
- External Defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs)
- Wearable Cardioverter Defibrillator (WCDs)
Breakup by End-User:
- Hospitals and Clinics
- Prehospital Care Settings
- Cardiac Centers
- Homecare Settings
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Zoll Medical Corporation, Biotronik, Boston Scientific Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic Inc., Nihon Kohden Corporation, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Stryker Corporation, etc.Key Questions Answered in This Report:
- How has the global defibrillators market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global defibrillators market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global defibrillators market and who are the key players?
- What is the degree of competition in the industry?
What is the estimated value of the Global Defibrillators Market?
What is the growth rate of the Global Defibrillators Market?
What is the forecasted size of the Global Defibrillators Market?
Who are the key companies in the Global Defibrillators Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | October 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 5.1 Billion |
| Forecasted Market Value ( USD | $ 7.4 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
Table of Contents
Companies Mentioned
- Asahi Kasei Zoll Medical Corporation
- Biotronik
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic Inc.
- Nihon Kohden Corporation
- Schiller AG
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Stryker Corporation
Methodology
LOADING...
